Pharma & Human Health
Parkinson’s Institute and Clinical Center and Axial Biotherapeutics Announce Collaboration to Target Gastrointestinal Metabolites That May Contribute to Parkinson’s Disease
Parkinson’s Institute and Clinical Center (PICC) and Axial Biotherapeutics announced a collaboration to investigate interventions targeting gastrointestinal (GI) metabolites that may cause Parkinson’s Disease (PD). The interventions, to be developed and identified by Axial, will […]